Latest news and press releases about Aurora Cannabis Inc. (ACB): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels.
Price
| Price | $3.83 |
| Market Cap | $237M |
| Exchange | NASDAQ |
| Country | CA |
Valuation Ratios
| Price / Book | 0.60 |
| EV / EBITDA | -3.37 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -21.00% |
| Return on Invested Capital | -15.55% |
| Return on Assets | -17.83% |
| Gross Margin | 32.08% |
| Operating Margin | -29.66% |
| Net Margin | -38.15% |
Related companies: ACRS · BIOA · CGC · EDIT · HITI · IRWD · LFCR
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of ACB: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks